Home | Research | Public
Publications and Presentations


PUBLICATIONS

Gray SM, Frankle WG, Sachs GS. STEP BD: A design for evaluating effectiveness of treatment for bipolar disorder. The Economics of Neuroscience 2001, 3(1): 65 68.

Sachs GS, Yan LJ, Swann AC, Allen MH. Integration of suicide prevention into outpatient management of bipolar disorder. Journal of Clinical Psychiatry 2001; 62 Suppl 25:3-11.

Sachs GS, Guille C, McMurrich SL. A clinical monitoring form for mood disorders. Bipolar Disorders 2002, 4(5): 323-327.

Perlick DA, Wolff N, Miklowitz DJ, Menard K, Rosenheck RR, & STEP-BD Family Experience Collaborative Study Group [abstract]. Development of an Integrated Model of Family Burden in Bipolar Illness. The Journal of Mental Health Policy and Economics, 2003, 6(Supplemental): 37.

Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese JR, Kupfer D, Rosenbaum, JF. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry 2003, 53: 1028-1042.

Thase ME, Bhargava M, Sachs GS. Treatment of bipolar depression: Current status, continued challenges, and the STEP-BD approach. Psychiatric Clinics of North America 2003, 26(2): 495-518.

Lembke A, Miklowitz DJ, Otto MW, Zhang H, Wisniewski SR, Sachs GS, Thase ME, Ketter TA. Psychosocial service utilization by patients with bipolar disorders: Data from the first 500 participants in the systematic treatment enhancement program. Journal of Psychiatric Practice 2004, 10(2): 81-87.

Perlis R, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, Bowden CL, Sachs GS, Nierenberg AA. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry 2004, 55: 875-81.

Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH. Pharmacotherapy for bipolar disorder and comorbid conditions: Baseline data from STEP-BD. Journal of Clinical Psychopharmacology 2004, 24: 512-520.

Marangell LB, Martinez JM, Ketter TA, Bowden CL, Goldberg JF, Calabrese JR, Miyahara S, Miklowitz DJ, Sachs GS, Thase ME. Lamotrigine use in patients with bipolar disorder: Data from the first 500 STEP-BD participants. Bipolar Disorders 2004; 6(2):139-43

Schneck CD, Miklowitz DJ, Calabrese JR, Allen MH, Thomas M, Wisniewski SR, Miyahara S, Shelton M, Ketter TA, Goldberg JF, Bowden CL, Sachs GS. Phenomenology of rapid cycling bipolar disorder: Data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder. American Journal of Psychiatry 2004; 161:1902-1908.

Kogan JN, Otto MW, Bauer MS, Dennehy EB, Miklowitz DJ, Zhang H, Ketter T, Rudorfer MV, Wisniewski SR, Thase ME, Calabrese J, Sachs GS. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Bipolar Disorders, 2004; 6: 460-69.

Sachs, GS. Strategies for improving treatment of bipolar disorder: Integration of measurement and management. Acta Psychiatrica Scandinavica, 2004; 110 (Suppl 422); 7-17.

Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH. Anxiety disorder comorbidity in bipolar disorder: Data from the first 500 STEP-BD participants. American Journal of Psychiatry, 2004;161(12):2222-9.

Morris CD, Miklowitz DJ, Wisniewski SR, Giese AA, Thomas MR and Allen MH. Care satisfaction, hope, and life functioning among adults with bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program. Comprehensive Psychiatry, 2005; 46: 98-104.

Allen MH, Chessick CA. On Instability of Symptoms in Recurrent Major Depression: A Prospective Study (letter). American Journal of Psychiatry, 2005; 162: 403.

Nierenberg AA, Miyahara S, Spencer T., Wisniewski SR, Otto MW, Simon NM, Pollack MH, Ostacher, MJ, Yan L, Siegel R.,, Sachs GS; Clinical and Diagnostic Implications of ADHD Comorbidity in Adults with Bipolar Disorder: Data from the First 500 STEP-BD Participants . Biological Psychiatry 2005; 57: 1467-1473.

Weiss RD, Ostacher M, Otto MW, Calabrese J, Fossey M., Wisniewski SR, Bowden C, Nierenberg AA, Pollack MH, Salloum I, Simon NM, Thase ME, Sachs GS. Recovery from Substance Use Disorder in Patients with Bipolar Disorder: Does it Matter? Journal of Clinical Psychiatry 2005; 6: 730-735.

Fagiolini A, Kupfer DJ, Masalehdan A, Scott JA, Houck PR, and Frank E. Functional Impairment in the remission phase of bipolar disorder. Bipolar Disorders 2005; 7: 281-5.

Waxmonsky JA, Thomas MR, Miklowitz DJ, Allen MH, Wisniewski SR, Zhang H, Ostacher M, Fossey MD. Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the Systematic Treatment Enhancement Program. General Hospital Psychiatry, 2005; 27:321-328.

Martinez, J, Marangell LB, Simon N, Wisniewski SR, Miyahara S, Harrington J, Pollock M, Sachs GS. Predictors of Serious Adverse Events though one-year of STEP-BD participation in 1000 Patients with Bipolar Disorder. Psychiatric Services, 2005; 56:1541-1548.

Goldberg J., Allen MH, Endick C, Chessick CA, Wisniewski SR, Miyahara S, Miklowitz DJ, Sagduyu K, Bowden C, Thase ME, Sachs GS. Suicidal ideation and naturalistic pharmacotherapy in STEP patients with bipolar disorder. Psychiatric Services 2005; 56:1534-1540.

Allen MH, Chessick CA, Miklowitz DJ, Goldberg JF, Wisniewski SR, Miyahara S, Calabrese JR, Marangell L, Bauer MS, Thomas MR, Bowden CL, Sachs GS. Contributors to Suicidal Ideation Among Bipolar Patients With and Without a History of Suicide Attempts. Suicide and Life Threatening Behavior, 2005; 35(6): 671-680

Bauer M, Wisniewski SR, Marangell LB, Chessick C, Allen MH, Dennehy EB, Miklowitz DJ, Thase ME, Sachs GS. Are Antidepressants Associated With New-Onset Suicidality in Bipolar Disorder? Journal of Clinical Psychiatry 2005; 67(1): 48-55.

Miklowitz, D. J., Wisniewski, S. R., Miyahara, S., Otto, M. W., & Sachs, G. S. Perceived criticism from family members as a predictor of the 1-year course of bipolar disorder. Psychiatry Research 2005; 136: 101-111

Perlis, RH, Delbello, MP, Miyahara, S, Wisniewski, S., Sachs GS, Nierenberg, AA. Revisiting depressive-prone bipolar disorder: Polarity of initial mood episode and disease course among bipolar I STEP-BD participants. Biological Psychiatry 2005; 58(7):549-553

Baldassano CF, Marangell LB, Gyulai L, Ghaemi N, Joffe H, Kim DR, Sagduyu K, Truman CJ, Wisniewski SR, Sachs GS, Cohen LS. Gender differences in the course of bipolar disorder: Data from the first 500 STEP-BD Participants. Bipolar Disorders 2005; 7(5): 465-470.

Mansour HA, Talkowski ME, Wood J, Bamne M, Chowdari KV, Allen M, Bowden CL, Calabrese J, El-Mallakh RS, Fagiolini A, Fossey MD, Friedman E, Gyulai L, Hauser P, Loftis J, Marangell L, Miklowitz D, Nierenberg AA, Patel J, Sachs G, Smoller J, Thase M, Frank E, Kupfer DJ, Nimgaonkar VL: Serotonin Gene Polymorphisms and Bipolar I Disorder: Focus on the Serotonin Transporter. Annals of Medicine 2005; 37(8):590-602.

Nierenberg AA, Ostacher M, Calabrese J, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS. Treatment-Resistant Bipolar Depression: A STEP-BD Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation With Lamotrigine, Inositol, or Risperidone. American Journal of Psychiatry 2006; 163: 210-216.

Perlis RH, Ostacher MJ, Patel J, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington N, Nierenberg AA, Sachs GS, Thase ME. Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163: 217-224.

Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, Miklowitz DJ, Coon KA, Ostacher M, Neel J, Thase ME, Sachs GS, Weiss RD. Validity of the Distinction Between Primary and Secondary Substance Use Disorder in Patients with Bipolar Disorder: Data from the First 1000 STEP-BD Participants. American Journal on Addictions 2006; 15(2):138-43

Zhang H, Bauer MS, Wisniewski S, Sachs GS, Thase ME. Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Comprehensive Psychiatry 2006; 47: 161-8.

Joffe H, Kim DR, Foris JM, Baldassano CF, Gyulai L, Hwang CH, McLaughlin WL, Sachs GS, Thase ME, Harlow BL, Cohen LS. Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression or healthy controls. J Clinical Psychiatry 2006; 67: 297-304.

Ghaemi SN, Hsu D, Thase ME, Wisniewski S, Nierenberg AA, Miyahara S, Sachs GS. Psychotropic drug prescription patterns in bipolar disorder: Data from the first 500 STEP-BD participants. Psychiatric Services, 2006; 57:660-665

Miklowitz DJ, Otto MW. New psychosocial interventions for bipolar disorder: A review of the literature and introduction of the systematic treatment enhancement program. Journal of Cognitive Psychotherapy 2006; 20(2): 215-230.

Miklowitz, D. J., Otto, M. W., Wisniewski, S. R., Araga, M., Frank, E., Reilly-Harrington, N., Lembke, A., & Sachs, G. S.. Psychosocial treatment utilization, symptomatic outcomes, and role functioning in a one-year follow-up of bipolar patients. Psychiatric Services 2006; 57(7), 959-965.

Otto MW, Simon NM, Wisniewski, SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu KA, Weiss RD, Miyahara S, Thase ME, Sachs GS, Pollack MH, for STEP-BD Investigators. One-Year Longitudinal Outcome for Bipolar Patients With and Without Anxiety Disorders: Data from the First 1000 Participants in the Systematic Treatment Enhancement Program. British Journal of Psychiatry 2006; 189: 20-25.

Friedman E, Bhargava M, Gyulai L, Landen M, Wisniewski S, Foris J, Thase ME. Seasonal changes in clinical status of bipolar patients in the STEP-BD 500 data set. Acta Psychiatrica Scandinavia 2006; 113(6): 510-517.

Joffe, H, Cohen, LS, Suppes, T., McLaughlin, WL, Lavori, P., Adams, JM, Hwang, CH, Hall, JE, Sachs, GS. Valproate is Associated with New-Onset Oligoamenorrhea with Hyperandrogenism In Women with Bipolar Disorder. Biological Psychiatry 2006; 59(11):1078-1086.

Wolff, Nancy; Perlick, Deborah A; Kaczynski, Richard; Calabrese, Joseph; Nierenberg, Andrew; Miklowitz, David J. Modeling Costs and Burden of Informal Caregiving for Persons with Bipolar Disorder. Journal of Mental Health Policy and Economics 2006; 9: 99-110.

Marangell LB, Suppes T, Ketter TA, Dennehy EB, Zboyan H, Kertz B, Nierenberg AA, Calabrese J, Wisniewski SR, Sachs GS. Omega-3 Fatty Acids in Bipolar Disorder: Clinical and Research Considerations. Prostaglandins, Leukotrienes & Essential Fatty Acids 2006; 75(4-5):315-321.

Marangell LM, Bauer MS, Dennehy EB, Wisniewski SR, Allen MH, Miklowitz D, Oquendo M, Frank E, Perlis R, Martinez JM, Fagiolini A, Otto MW, Chessick C, Zboyan HA, Miyahara S, Sachs G, Thase ME. Prospective Predictors of Suicide and Suicide Attempts in 1556 Patients with Bipolar Disorders Followed for up to 2 Years. Bipolar Disorders 2006; 8: 566-575.

Gonzalez, Thompson, Escamilla, Araga, Singh, Farrelly, Thase, Bowden. Illness and Treatment Characteristics among European Americans, African Americans and Latinos in the First 2000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder. Psychopharmacology Bulletin 2007; 40(1): 31-46.

PRESENTATIONS AT PROFESSIONAL MEETINGS (partial listing)

Gonzalez J. Illness characteristics in Latino and Anglo individuals with bipolar disorder. Presented at the Latino Mental Health Conference, November 2002, Princeton, NJ.

Goldberg JF, Michaelis BH, Endick CJ, Singer TM, Allen MH, Sagduyu K, Calabrese JR, Sachs GS, Marangell LB, Thase ME, Ketter TA, Ghaemi SN. Suicidality and differential pharmacotherapy in the STEP 500 bipolar cohort. Presented at the 41st Annual American College of Nueropsychopharmacology meeting, December 2002, Puerto Rico.

Sachs, GS. Effectiveness of psychosocial therapies for bipolar disorder. Presented at the 41st Annual American College of Neuropsychopharmacology, December 2002, Puerto Rico.

Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH. Anxiety disorder comorbidity in bipolar disorder: Data from the first 500 STEP participants. Presented at the 41st Annual American College of Neuropsychopharmacology, December 2002, Puerto Rico.

Chessick CA, Allen MH, Goldberg JF. Bipolar disorder with/without suicidal ideation, data from the first 500 STEP-BD participants. Presented at Annual Meeting of the American Association of Suicidology, Santa Fe, April 2003, New Mexico.

Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Miyahara S, Sachs GS. Pharmacologic treatment of bipolar disorder: medication use in STEP-BD. Presented at the 156th Annual Meeting of the American Psychiatric Association, May 2003, San Francisco, CA.

Hsu DJ, Ghaemi SN, Soldani F, El-Mallakh RS, Baldassano CF, Rosenquist KJ, Goodwin FK. Patient bias and open randomization in bipolar trials (abstract). Presented at the 156th Annual Meeting of the American Psychiatric Association, May 2003, San Francisco, CA.

Perlick DA, Miklowitz DJ, Menard KR, Wolff N, Marangell L, Calabrese J, Ostacher M, Patel J, Ketter T, Rosenheck RR. Scope and correlates of caregiver burden in bipolar disorder. Presented at the 156th Annual Meeting of the American Psychiatric Association, May 2003, San Francisco, CA.

Schneck CD, Calabrese JR, Miklowitz DJ, Wisniewski SR. Phenomenology of rapid-cycling bipolar disorder from the STEP 500. Presented at the 156th Annual Meeting of the American Psychiatric Association, May 2003, San Francisco, CA.

Simon NM, Sagduyu K, Otto MW, Wisniewski SR, Fossey M, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH. Anxiety comorbidity in bipolar disorder: The first 500 STEP-BD participants. Presented at the 156th Annual Meeting of the American Psychiatric Association, May 2003, San Francisco, CA.

Truman CJ, Baldassano CF, Goldberg JF, Wisniewski, SR, Thase ME, Sachs GS. History of antidepressant-induced mania in the STEP 500. Presented at the 156th Annual Meeting of the American Psychiatric Association, May 2003, San Francisco, CA.

Joffe H, Cohen LS, Suppes T, Wisniewski S, Dennehy EB, Somers P, Reilly C, McLaughlin W, Hall JE, Sachs G. Treatment-emergent polycystic ovarian syndrome in women with bipolar disorder: Interim report of the STEP-BD ancillary study. Presented at 43rd Annual New Clinical Drug Evaluation Unit meeting, May 2003, Boca Raton, FL.

Martinez JM, Marangell LB, Ketter TA, Bowden CL, Goldberg JF, Calabrese JR, Thase ME. Lamotrigine use in patients with bipolar disorder: Baseline data from the STEP-BD 500. Presented at the 43rd Annual New Clinical Drug Evaluation Unit meeting, May 2003, Boca Raton, FL.

Perlick D, Rosenheck RA, Menard KR, Desai R, Miklowitz D, Wolff N, Calabrese J, Marangell L, Ostacher M, Patel J, Schumacher M. Correlates of self-reported physical health and health behavior among caregivers of patients with bipolar disorder. Presented at the 43rd Annual New Clinical Drug Evaluation Unit meeting, May 2003, Boca Raton, FL.

Perlick D, Rosenheck R, Menard KR, Woods SW, Sernyak M, Neugebauer SR, Baxter N, Lippman LI, Miklowitz DJ, Morris C, Schumacker MA, Alarcon A, Ketter T. Needs of family caregivers of patients with bipolar illness and schizophrenia: Preliminary data using the Family Assessment of Need for Service (FANS). Presented at the 43rd Annual New Clinical Drug Evaluation Unit meeting, May 2003, Boca Raton, FL.

Chessick C, Allen MH, Goldberg J. Bipolar disorder with/without suicidal ideation/behavior. Presented at the 5th International Conference on Bipolar Disorder, June 2003, Pittsburgh, PA.

Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Miyahara S, Sachs GS. Pharmacologic treatment of bipolar disorder: Psychotropic medication use in the first 500 patients of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Presented at the 5th International Conference on Bipolar Disorder, June 2003, Pittsburgh, PA.

Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH. Anxiety disorder comorbidity in bipolar disorder: Data from the first 500 STEP participants. Presented at the 37th Annual Meeting of the Association for Advancement of Behavior Therapy, November 2003, Boston, MA.

Ghaemi SN, El-Mallakh RS, Baldassano CF, Ostacher M, Hsu DJ, Pardo TB, Hennen J, Sachs GS, Baldessarini RJ, Goodwin FK. Antidepressant treatment in bipolar depression: Long-term outcome. Presented at the 42nd Annual American College of Neuropsychopharmacology meeting, December 2003, Puerto Rico.

Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH. Pharmacotherapy for bipolar disorder and comorbid conditions: Baseline data from STEP-BD. 42nd Annual Meeting of the American College of Neuropsychopharmacology, December 2003, San Juan, Puerto Rico.

Alarcon AM, Baloga-Mintz, NM, Jaros SL, Wang PW, Perlick DA, Nowakowska C, Ketter TA. Enhanced creativity in bipolar disorder patients compared to caregivers. Presented at the 157th Annual Meeting of the American Psychiatric Association, May 2004, New York, NY.

Jaros SL, Schumacher MR, Culver JL, Alarcon AM, Baloga-Mintz N, Perlick DA, Ketter TA. Stigma by proxy: Exploring caregivers of patients with bipolar illnesses. Presented at the 157th Annual Meeting of the American Psychiatric Association, May 2004, New York, NY.

Ostacher M, Perlick DA, Miklowitz D, Eidelman P, Calabrese J, Fossey M, Gonzalez J, Ketter T, Marangell LB, Patel J, Wolff N, Rosenheck R. Patient substance or alcohol abuse and caregiver burden in bipolar disorder. Presented at the 157th Annual Meeting of the American Psychiatric Association, May 2004, New York, NY.

Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH. Pharmacotherapy for bipolar disorder and comorbid conditions: Baseline data from STEP-BD. Presented at the 157th Annual Meeting of the American Psychiatric Association, May 2004, New York, NY.

Kogan J, Bauer MS, Wisniewski SR, Marangell LB, Thase ME, Sachs GS. Paroxetine and suicidality in a high-risk population. Presented at the 44th Annual New Clinical Drug Evaluation Unit meeting, June 2004, Phoenix, AZ.

Morris CD, Miklowitz DJ, Wisniewski SR, Giese AA, Allen MH, Thomas MR. Care satisfaction, hope, and life functioning among adults with bipolar disorder: Data from the first 1,000 STEP-BD participants. Presented at the 44th Annual New Clinical Drug Evaluation Unit meeting, June 2004, Phoenix, AZ.

Schneck CD, Miklowitz DJ, Calabrese JR, Allen MH, Thomas MR, Wisniewski SR, Miyahara S, Shelton MD, Ketter TA, Goldberg JF, Bowden CL, Sachs GS. Phenomenology of rapid cycling bipolar disorder: Data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder. Presented at the 44th Annual New Clinical Drug Evaluation Unit meeting, June 2004, Phoenix, AZ.

Otto MW, Hollon SD. The course of bipolar disorder. Attention to sample characteristics, comorbidity, and treatment variables. Presented at the 38th annual Association for Advancement of Behavioral Therapy meeting, November 2004, New Orleans, LA.

Kogan, J. Demographic and Diagnostic Characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Presented at the 38th annual Association for Advancement of Behavioral Therapy meeting, November 2004, New Orleans, LA.

Miklowitz DJ. Psychosocial treatment utilization in a naturalistic study cohort of bipolar adults. Presented at the 38th annual Association for Advancement of Behavioral Therapy meeting, November 2004, New Orleans, LA.

Otto MW. One-year longitudinal outcome for bipolar patients with and without anxiety disorders. Presented at the 38th annual Association for Advancement of Behavioral Therapy meeting, November 2004, New Orleans, LA.

Joffe H, Kim DR, Foris JM, Baldassano CF, Gyulai L, Hwang C, McLaughlin W, Sachs G, Thase M, Harlow BL, Cohen LS. Menstrual dysfunction prior to onset of psychiatric illness is more common in women with bipolar disorder than in women with unipolar depression or healthy controls. Presented at the 32nd Annual North American Society for Psychosocial Obstetrics and Gynecology meeting, February 2005, Coronado, CA

Gyulai L., et al. Determinants of Functioning in bipolar disorders: Data from the first 500 participants of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Presented at the WPA Thematic Conference: Quality and Outcome Research in Psychiatry, June 2005, Valencia, Spain.

Gyulai L, Bauer MS, Marangell LB, Wisniewski, SR, Dennehy EB, Otto MW, Zhang H, Miklowitz D, Kogan J, Baldassano CF, Kim DR, Hahn CG, Rapaport MH, Thase ME, Sachs GS. Determinants of functioning in bipolar disorders: a study of patients in the Systematic Treatment Enhancement Program for Bipolar Disorders (STEP-BD). Poster presented at the 6th International Conference on Bipolar Disorder, June 16-18, 2005, Pittsburgh, PA.

Ostacher MJ, Nierenberg AA, Perlis RH, Marzilli G, Eidelman P, Hwang CH, Tran TB, Weiss RD, Sachs GS. The association between smoking and clinical course in bipolar disorder. Poster presented at the 6th International Conference on Bipolar Disorder, June 16-18, 2005, Pittsburgh, PA.


Home | Research | Public | Publications and Presentations